clarithromycin
Term · Oncology and biomedicine · MLC-T-ONC-001796
An antibiotic drug used in the treatment of infections. It belongs to the family of drugs called macrolides.
A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression.
| Identifier | MLC-T-ONC-001796 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CLARITH |
| Synonyms | Abbott-56268 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001796",
"term": "clarithromycin",
"field": "Oncology and biomedicine",
"definitions": [
"An antibiotic drug used in the treatment of infections. It belongs to the family of drugs called macrolides.",
"A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression."
],
"abbreviation": "CLARITH",
"synonyms": [
"Abbott-56268"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/clarithromycin/"
}
Record 4,915 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.